Alexandra Eichten

4.5k total citations · 2 hit papers
20 papers, 3.6k citations indexed

About

Alexandra Eichten is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Alexandra Eichten has authored 20 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Alexandra Eichten's work include Angiogenesis and VEGF in Cancer (9 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer-related Molecular Pathways (4 papers). Alexandra Eichten is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer-related Molecular Pathways (4 papers). Alexandra Eichten collaborates with scholars based in United States, Netherlands and Denmark. Alexandra Eichten's co-authors include Lisa M. Coussens, Karin E. de Visser, M. Hinz, Claus Scheidereit, Daniel Krappmann, Mike Strauss, Karl Münger, Valerie Zacny, John R. Basile and Miranda Grace and has published in prestigious journals such as Nature reviews. Cancer, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Alexandra Eichten

20 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paradoxical roles of the immune system during cancer development

2006 1.7k citations Karin E. de Visser, Alexandra Eichten et al. Nature reviews. Cancer profile →
NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G ₀ /G ₁ -to-S-Phase Transition

1999 689 citations M. Hinz, Daniel Krappmann et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexandra Eichten United States	14	1.6k	1.5k	1.2k	981	497	20	3.6k
Paola Cappello Italy	38	1.5k 0.9×	1.6k 1.1×	1.8k 1.5×	837 0.9×	326 0.7×	97	4.0k
Antonella Sassano United States	38	2.1k 1.3×	1.2k 0.8×	1.2k 1.0×	590 0.6×	288 0.6×	66	3.6k
Mary Gerhart United States	14	1.7k 1.0×	1.2k 0.8×	1.4k 1.2×	902 0.9×	451 0.9×	22	4.2k
Adam S. Asch United States	31	1.7k 1.1×	1.3k 0.9×	1.0k 0.9×	579 0.6×	622 1.3×	98	4.6k
Xiaofeng Jiang China	35	3.0k 1.9×	1.3k 0.9×	865 0.7×	984 1.0×	337 0.7×	73	4.4k
Manfred Kunz Germany	34	2.3k 1.4×	806 0.5×	970 0.8×	1.2k 1.2×	327 0.7×	114	3.8k
Wei Tong United States	34	2.7k 1.7×	948 0.6×	1.1k 1.0×	576 0.6×	382 0.8×	84	5.6k
Wen Yang China	26	1.9k 1.2×	1.1k 0.7×	633 0.5×	1.2k 1.2×	516 1.0×	71	3.7k
Xing Huang China	29	1.7k 1.0×	1.2k 0.8×	838 0.7×	658 0.7×	368 0.7×	110	3.2k
Zhong Chen United States	36	2.4k 1.5×	1.7k 1.1×	812 0.7×	1.5k 1.5×	265 0.5×	74	4.2k

Countries citing papers authored by Alexandra Eichten

Since Specialization

Citations

This map shows the geographic impact of Alexandra Eichten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Eichten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Eichten more than expected).

Fields of papers citing papers by Alexandra Eichten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Eichten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Eichten. The network helps show where Alexandra Eichten may publish in the future.

Co-authorship network of co-authors of Alexandra Eichten

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Eichten. A scholar is included among the top collaborators of Alexandra Eichten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Eichten. Alexandra Eichten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qi, Asma Parveen, Alexander P. Adler, et al.. (2020). Heterogeneity and chimerism of endothelial cells revealed by single-cell transcriptome in orthotopic liver tumors. Angiogenesis. 23(4). 581–597. 26 indexed citations

Zhao, Qi, Alexandra Eichten, Asma Parveen, et al.. (2018). Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment. Cancer Research. 78(9). 2370–2382. 142 indexed citations

Eichten, Alexandra, Alexander P. Adler, Li Zhang, et al.. (2016). Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade. Cancer Research. 76(8). 2327–2339. 47 indexed citations

Adler, Alexander P., Christopher Daly, Asma Parveen, et al.. (2014). Abstract 4492: Blockade of angiopoietin-2 or Tie2 is equally effective at inhibiting tumor growth and reducing tumor vessel density in most human tumor xenograft models. Cancer Research. 74(19_Supplement). 4492–4492. 2 indexed citations

Daly, Christopher, Alexandra Eichten, Carla Castanaro, et al.. (2012). Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition. Cancer Research. 73(1). 108–118. 180 indexed citations

Zhang, Li, et al.. (2012). Abstract 2723: Sarilumab (REGN88), a fully-human anti-IL6R antibody, inhibits tumor growth in preclinical models, as a single agent and in combination with the VEGF blocker aflibercept. Cancer Research. 72(8_Supplement). 2723–2723. 6 indexed citations

Eichten, Alexandra, Alexander P. Adler, Jennifer M. Griffith, et al.. (2012). Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models. Angiogenesis. 16(2). 429–441. 28 indexed citations

Daly, Christopher, Carla Castanaro, Alexander P. Adler, et al.. (2011). Abstract 3290: REGN910, a fully-human, Ang2-specific monoclonal antibody, inhibits tumor growth as a monotherapy and dramatically potentiates the effects of VEGF Trap (aflibercept). Cancer Research. 71(8_Supplement). 3290–3290. 1 indexed citations

Adler, Alexander P., Alexandra Eichten, Yi Wei, et al.. (2008). Identifying tumor vascular genes regulated by Aflibercept (VEGF Trap). Cancer Research. 68. 2497–2497. 1 indexed citations

10.

Egeblad, Mikala, Hongxing Shen, Danielle J. Behonick, et al.. (2007). Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development. Developmental Dynamics. 236(6). 1683–1693. 39 indexed citations

11.

Eichten, Alexandra, William C. Hyun, & Lisa M. Coussens. (2007). Distinctive Features of Angiogenesis and Lymphangiogenesis Determine Their Functionality during De novo Tumor Development. Cancer Research. 67(11). 5211–5220. 28 indexed citations

12.

Egeblad, Mikala, Hongxing Shen, Lisa J. Wilmes, et al.. (2007). Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development. Developmental Dynamics. 236(8). 3 indexed citations

13.

Junankar, Simon, et al.. (2006). Analysis of Immune Cell Infiltrates during Squamous Carcinoma Development. Journal of Investigative Dermatology Symposium Proceedings. 11(1). 36–43. 24 indexed citations

14.

Visser, Karin E. de, Alexandra Eichten, & Lisa M. Coussens. (2006). Paradoxical roles of the immune system during cancer development. Nature reviews. Cancer. 6(1). 24–37. 1740 indexed citations breakdown →

15.

Eichten, Alexandra, Hongxing Shen, & Lisa M. Coussens. (2005). Three‐Dimensional Visualization of Blood and Lymphatic Vasculature in Tissue Whole Mounts Using Confocal Microscopy. Current Protocols in Cytometry. 32(1). Unit 12.5–Unit 12.5. 7 indexed citations

16.

Basile, John R., Alexandra Eichten, Valerie Zacny, & Karl Münger. (2003). NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes.. PubMed. 1(4). 262–70. 57 indexed citations

17.

Eichten, Alexandra, et al.. (2003). Molecular pathways executing the “trophic sentinel” response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation. Virology. 319(1). 81–93. 24 indexed citations

18.

Eichten, Alexandra, Matthew D Westfall, Jennifer A. Pietenpol, & Karl Münger. (2002). Stabilization and Functional Impairment of the Tumor Suppressor p53 by the Human Papillomavirus Type 16 E7 Oncoprotein. Virology. 295(1). 74–85. 50 indexed citations

19.

Münger, Karl, John R. Basile, Stefan Duensing, et al.. (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene. 20(54). 7888–7898. 468 indexed citations

20.

Hinz, M., et al.. (1999). NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G ₀ /G ₁ -to-S-Phase Transition. Molecular and Cellular Biology. 19(4). 2690–2698. 689 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact